Inventory increased 34.2%
Inventory changed +34.2% from the comparable as-filed period.
Ranked by interpretable importance, issuer history, magnitude, and accounting profile. No directional recommendation.
Inventory changed +34.2% from the comparable as-filed period.
Net income changed +47.1% from the comparable as-filed period.
Gross profit changed +60.1% from the comparable as-filed period.
Operating income changed -71.2% from the comparable as-filed period.
Operating margin changed -521 basis points from the comparable as-filed period.
Research & development changed +141.2% from the comparable as-filed period.
Revenue changed +56.0% from the comparable as-filed period.
Selling, general & administrative changed +56.3% from the comparable as-filed period.
Gross margin changed +205 basis points from the comparable as-filed period.
Cash & equivalents changed -9.6% from the comparable as-filed period.
Method Importance combines metric-family relevance, magnitude, issuer-history unusualness, persistence, and financial-statement significance. It is analytical prioritization, not a legal materiality conclusion or investment signal.